Sfoglia per Autore
Minimal laboratory investigation of uremic patients.
1985 D. Brancaccio, A. Minetti, E. Sabbioni, R. Pietra, O. Bugiani, G. Como, M. Gallieni
Desferrioxamine infusion test
1987 P. Gilli, F. Malacarne, A. Storari, D. Brancaccio, M. Gallieni, M. Andriani, A. Piccoli, M. Nordio
Aluminum-dependent transfusions in dialysis
1988 D. Brancaccio, M. Gallieni, A. Anelli, P. Padovese
Dialysis amyloidosis with massive popliteal deposition of beta 2-microglobulin amyloid
1988 D. Brancaccio, M.A. Gallieni, P. Padovese, A. Anelli, G. Coggi, C.M. Uslenghi
Beta-2-microglobulin amyloidosis in uremic dialyzed patients
1989 D. Brancaccio, M. Gallieni, P. Padovese, A. Anelli
Substitution of calcium carbonate for aluminum hydroxide in patients on hemodialysis : Effects on acidosis, on parathyroid function, and on calcemia
1989 A. Anelli, D. Brancaccio, R. Damasso, P. Padovese, M.A. Gallieni, S. Garella
Overt dialysis encephalopathy and mildly raised plasma aluminium
1989 D. Brancaccio, P. Padovese, M. Gallieni, A. Anelli, M. Lazzaroni, G. Avanzini
Beta-2-microglobulin amyloidosis and osteo-articular pathology of the uremic patient on regular dialysis
1990 D. Brancaccio, A. Anelli, M. Gallieni, P. Padovese, G. Coggi, C. Uslenghi
Desferrioxamine versus erythropoietin for treatment of dialysis anaemia
1990 P. Padovese, M. Gallieni, C. Galmozzi, D. Brancaccio
Desferrioxamine infusion can modify EEG tracing in haemodialysed patients
1991 D. Brancaccio, G. Avanzini, P. Padovese, M. Gallieni, S. Franceschetti, F. Panzica, A. Anelli, G. Colantonio, D. Martinelli, O. Bugiani
Indirect evidence for transfusion role in conditioning hepatitis C virus prevalence among dialysis patients
1991 G. A. Moroni, P. Cori, F. Marelli, M. Del Prete, P. Padovese, M. Gallieni, A. Anelli, D. Brancaccio
Trace elements in dialysis fluids and assessment of the exposure of patients on regular hemodialysis, hemofiltration and continuous ambulatory peritoneal dialysis
1992 P. Padovese, M. Gallieni, D. Brancaccio, R. Pietra, S. Fortaner, E. Sabbioni, C. Minoia, K. Markakis, A. Berlin
Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patients. Italian Group for the Study of Intravenous Calcitriol
1992 M. Gallieni, D. Brancaccio, P. Padovese, D. Rolla, P. Bedani, G. Colantonio, C. Bronzieri, B. Bagni, G. Tarolo
Differential catabolism of 22-oxacalcitriol and 1,25-dihydroxyvitamin D3 by normal human peripheral monocytes
1993 S. Kamimura, M. Gallieni, N. Kubodera, Y. Nishii, A. J. Brown, E. Slatopolsky, A. Dusso
Which is the preferred treatment of advanced hyperparathyroidism in a renal patient? I. Medical intervention is the primary option in the treatment of advanced hyperparathyroidism in chronic renal failure
1994 M. Gallieni, D. Brancaccio
Recent advances in intravenous calcitriol treatment
1994 D. Brancaccio, M. Gallieni
Effect of gastric acid secretion on intestinal phosphate and calcium absorption in normal subjects
1995 G. Graziani, G. Como, S. Badalamenti, S. Finazzi, A. Malesci, M. Gallieni, D. Brancaccio, C. Ponticelli
Kinetics of monocyte 1α-hydroxylase in renal failure
1995 M. Gallieni, S. Kamimura, A. Ahmed, E. Bravo, J. Delmez, E. Slatopolsky, A. Dusso
Vitamin D metabolism in chronic renal failure
1995 M. Gallieni, M. Cozzolino, D. Brancaccio
Uncomplicated central vein catheterization of high risk patients with real time ultrasound guidance
1995 M. Gallieni, M. Cozzolino
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile